ACP Releases Practice Advice for Short-Course Antibiotics in Common Infections
The American College of Physicians convened a panel to identify best practices for the use of short-course antibiotics in the management of common infections.
Urinary Tract Infections
Urinary Tract Infections
Latest News
Travelers’ Diarrhea Significantly Increases Urinary Tract Infection Risk
Researchers assessed whether there is an association between urinary tract infection incidence and international travel.
Gut Dysbiosis Identified in Women With Recurrent UTI
Women with rUTIs have a gut microbiome that is significantly depleted in microbial richness and butyrate-producing bacteria.
Patient Race May Be a Proxy for Other Factors in Predictive Models for UTI Risk in Children
In this meta-analysis, researchers assessed whether patient race is a proxy for other factors in predictive models that show an association between race and urinary tract infection risk.
Zerbaxa Approved for Complicated Pediatric Intra-abdominal, Urinary Tract Infections
The approvals were based on data from pediatric trials evaluating treatment for complicated intra-abdominal infections and complicated urinary tract infections.
Role of Race in Calculating UTI Risk in Children Reassessed
The variable race is associated with UTI in children, but it can be replaced with history of UTI and duration of fever in a previously developed prediction tool.
FDA: Sotrovimab No Longer Authorized to Treat COVID-19 in Any US Region
As of April 5, 2022, CDC Nowcast data reported that the BA.2 subvariant accounted for more than 50% of cases in all US states and territories.
Oral Tebipenem Effectively Treats Complicated UTI, Pyelonephritis
Tebipenem pivoxil hydrobromide is an orally bioavailable carbapenem with activity against uropathogenic Enterobacterales.
Cefepime-Taniborbactam Bests Meropenem in Complicated UTI Trial
The phase 3 CERTAIN-1 study compared the efficacy and safety of cefepime-taniborbactam to meropenem in 661 adults with cUTI.
MV140 Vaccine May Prevent Recurrent Urinary Tract Infections
MV140 is a sublingual vaccine of whole-cell inactivated bacteria that may be an alternative to frequent antibiotics for recurrent urinary tract infections.
Antibiotic Stewardship Increases Use of Guideline-Concordant Antibiotics for UTI
Researchers conducted a study to assess the effect of an antibiotic stewardship program on the use of appropriate antibiotic therapy among patients with urinary tract infections in the ED.
Tebipenem HBr Gets Priority Review for Oral Treatment of Complicated UTI
The application includes data from the phase 3 ADAPT-PO trial, which evaluated the efficacy and safety of tebipenem HBr in 868 adults with cUTI or acute pyelonephritis.
Safety, Efficacy of Aminoglycosides or Polymyxin Monotherapy for Complicated UTI
Researchers conducted a study to assess the safety and efficacy of aminoglycosides or polymyxin monotherapy for the treatment of adults with complicated urinary tract infections caused by extensively drug-resistant Pseudomonas aeruginosa.
Educating Nursing Care Facility Staff Decreases Inappropriate Antibiotic Treatment for Urinary Tract Infection
Researchers sought to determine whether an intervention to improve the knowledge and communication skills of nursing care facility staff decreases the number of inappropriate antibiotic prescriptions for patients with suspected urinary tract infection.
Probability of Progression to Complicated Urinary Tract Infection in Women With Antimicrobial-Resistant Isolates
Study finds that among women with uncomplicated urinary tract infection (UTI), those with antimicrobial-resistant isolates are at increased risk for progression to complicated UTI vs those with susceptible isolates.
Effect of Probenecid on Cephalexin Pharmacokinetics and Pharmacodynamics
Researchers conducted a crossover study to determine whether probenecid and cephalexin administered together increases the clinical benefits of cephalexin.
Community-Acquired Urinary Tract Infection: Adverse Effects of Cotrimoxazole vs Fluoroquinolones
Investigators conducted a cohort study that compared adverse effects and outcomes among patients with community-acquired urinary tract infection treated with cotrimoxazole vs fluoroquinolones.
Frailty Ups Risk for Urinary Tract Infections in Patients With Diabetes, CKD
More severe frailty predicted a higher risk of UTIs.
Study Supports Shorter Antibiotic Course for Afebrile Men With UTI
The double-blinded, placebo-controlled noninferiority study included a total of 272 afebrile men from 2 US Veterans Affairs medical centers.
FDA Needs More Data on Sulopenem for Uncomplicated UTI
The NDA submission was supported by data from the phase 3 SURE1 clinical trial.
UTI Study Maps Escherichia coli Antimicrobial Resistance Trends in the United States
Investigators evaluated resistance to fluoroquinolones, nitrofurantoin, and trimethoprim-sulfamethoxazole in patients with uncomplicated urinary tract infection.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Urinary Tract Infections
Loading... 
Loading...